CellR4 2021; 9: e3093 DOI: 10.32113/cellr4_20213_3093 The pancreatic islet: a micro-organ in control Abdulreda M. H. Department of Surgery, Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA mabdulreda@miami.edu , Berggren P. O. Department of Surgery, Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA per-olof.berggren@ki.se
CellR4 2021; 9: e3083 DOI: 10.32113/cellr4_20213_3083 Why pancreatic islets should be regarded and regulated like organs Weir G. C. Section on Islet Cell and Regenerative Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA gordon.weir@joslin.harvard.edu , Bonner-Weir S. Section on Islet Cell and Regenerative Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA
CellR4 2019; 7: e2772 DOI: 10.32113/cellr4_201910_2772 Islet transplantation in Italy Bertuzzi F. SSD Diabetology, Niguarda Hospital, Milan, Italy Federico.Bertuzzi@ospedaleniguarda.it
CellR4 2019; 7: e2774 DOI: 10.32113/cellr4_201910_2774 Not reimbursing islet transplantation creates discrimination against patients with type 1 diabetes Berney T. Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland thierry.berney@hcuge.ch
CellR4 2019; 7: e2768 DOI: 10.32113/cellr4_201910_2768 Transplanting islet cells can fix brittle diabetes. Why isn’t it available in the U.S.? Ricordi C. Department of Surgery and Diabetes Research Institute, University of Miami, Miami, FL, USA ricordi@miami.edu , Japour A. Medical Director, ICON Plc, Miami, FL, USA